<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE CTGovProtocol >
<CTGovProtocol id="CDR1">
  <IDInfo>
    <OrgStudyID>Lorem ipsum 123123</OrgStudyID>
    <NCTID>NCT00000001</NCTID>
  </IDInfo>
  
  <BriefTitle>Lorem ipsum 1 brief</BriefTitle>
  <OfficialTitle>Lorem ipsum 1</OfficialTitle>
  <CurrentProtocolStatus>Completed</CurrentProtocolStatus>
  <StartDate DateType="Actual">October 2002</StartDate>
  <ProtocolPhase>Phase I</ProtocolPhase>
  <ProtocolPhase>Phase II</ProtocolPhase>
  <ProtocolPhase>Phase III</ProtocolPhase>
  <ProtocolDetail>
    <StudyType>Clinical trial</StudyType>
    <StudyCategory>
      <StudyCategoryName>Treatment</StudyCategoryName>
      <Intervention>
        <InterventionType ref="CDR0000042070">radioimmunotherapy</InterventionType>
        <InterventionTypeParent ref="CDR0000039007">radioisotope therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000038085">radiation therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000041549">antibody therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000579648">immunotherapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000040815">biological therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000681313">molecularly targeted biological therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000650168">molecularly targeted therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000680249">targeted therapy</InterventionTypeParent>
        <InterventionNameLink ref="CDR0000038483">drug11</InterventionNameLink>
      </Intervention>
      <Intervention>
        <InterventionType ref="CDR0000039986">monoclonal antibody therapy</InterventionType>
        <InterventionTypeParent ref="CDR0000041549">antibody therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000579648">immunotherapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000040815">biological therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000681313">molecularly targeted biological therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000650168">molecularly targeted therapy</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000680249">targeted therapy</InterventionTypeParent>
        <InterventionNameLink ref="CDR0000038483">drug12</InterventionNameLink>
      </Intervention>
      <Intervention>
        <InterventionType ref="CDR0000039455">chemotherapy</InterventionType>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
        <InterventionNameLink ref="CDR0000039244">drug12</InterventionNameLink>
        <InterventionNameLink ref="CDR0000039748">drug13</InterventionNameLink>
      </Intervention>
      <Intervention>
        <InterventionType ref="CDR0000038581">multimodality therapy</InterventionType>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
        <InterventionNameLink ref="CDR0000357562">drug14</InterventionNameLink>
      </Intervention>
      <Intervention>
        <InterventionType ref="CDR0000038727">allogeneic bone marrow transplantation</InterventionType>
        <InterventionTypeParent ref="CDR0000039793">bone marrow transplantation</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000573940">transplantation</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
      </Intervention>
      <Intervention>
        <InterventionType ref="CDR0000041174">peripheral blood stem cell transplantation</InterventionType>
        <InterventionTypeParent ref="CDR0000579886">hematopoietic stem cell transplantation</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000573940">transplantation</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000572892">therapeutic procedure</InterventionTypeParent>
        <InterventionTypeParent ref="CDR0000256087">Intervention or procedure</InterventionTypeParent>
      </Intervention>
    </StudyCategory>
  </ProtocolDetail>
  <Eligibility>
    <HealthyVolunteers>No</HealthyVolunteers>
    <LowAge>18</LowAge>
    <HighAge>70</HighAge>
    <AgeText>18 to 70</AgeText>
    <Gender>Both</Gender>
    <Diagnosis>
      <SpecificDiagnosis ref="CDR0000040561">recurrent adult Burkitt lymphoma</SpecificDiagnosis>
      <DiagnosisParent ref="CDR0000038422">adult Burkitt lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042800">adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000038957">non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000041429">lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000039800">hematopoietic/lymphoid cancer</DiagnosisParent>
      <DiagnosisParent ref="CDR0000043666">body system/site cancer</DiagnosisParent>
      <DiagnosisParent ref="CDR0000041060">malignant neoplasm</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042756">aggressive, recurrent adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000040327">recurrent adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042760">aggressive, adult non-Hodgkin lymphoma</DiagnosisParent>
    </Diagnosis>
    <Diagnosis>
      <SpecificDiagnosis ref="CDR0000040557">recurrent adult diffuse large cell lymphoma</SpecificDiagnosis>
      <DiagnosisParent ref="CDR0000038401">adult diffuse large cell lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042800">adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000038957">non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000041429">lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000039800">hematopoietic/lymphoid cancer</DiagnosisParent>
      <DiagnosisParent ref="CDR0000043666">body system/site cancer</DiagnosisParent>
      <DiagnosisParent ref="CDR0000041060">malignant neoplasm</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042756">aggressive, recurrent adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000040327">recurrent adult non-Hodgkin lymphoma</DiagnosisParent>
      <DiagnosisParent ref="CDR0000042760">aggressive, adult non-Hodgkin lymphoma</DiagnosisParent>
    </Diagnosis>
  </Eligibility>
  <VerificationDate>January 2012</VerificationDate>
  <LastChangedDate>January 5, 2012</LastChangedDate>
</CTGovProtocol>
